Schulhoff & CO Inc Abb Vie Inc. Transaction History

Schulhoff & CO Inc

$206 Million
Q2 2024

A detailed history of Schulhoff & CO Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Schulhoff & CO Inc holds 27,903 shares of ABBV stock, worth $5.42 Million. This represents 2.32% of its overall portfolio holdings.

Number of Shares

27,903

Previous 27,903 -0.0%

Holding current value

$5.42 Million

Previous $5.08 Million 5.83%

% of portfolio

2.32%

Previous 2.38%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$159.82 - $182.1 $52,740 - $60,093	-330 Reduced 1.17%	27,903 $5.08 Million
Q4 2023 Feb 07, 2024	SELL	$137.6 - $154.97 $17,200 - $19,371	-125 Reduced 0.44%	28,233 $4.38 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $432,831 - $501,066	-3,240 Reduced 10.25%	28,358 $4.23 Million
Q2 2023 Aug 01, 2023	SELL	$132.51 - $164.9 $47,703 - $59,364	-360 Reduced 1.13%	31,598 $4.26 Million
Q1 2023 May 05, 2023	SELL	$144.61 - $166.54 $7,230 - $8,327	-50 Reduced 0.16%	31,958 $5.09 Million
Q4 2022 Feb 09, 2023	SELL	$138.31 - $165.87 $55,324 - $66,348	-400 Reduced 1.23%	32,008 $5.18 Million
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $40,263 - $46,179	-300 Reduced 0.92%	32,408 $4.35 Million
Q2 2022 Aug 05, 2022	SELL	$137.62 - $174.96 $4,128 - $5,248	-30 Reduced 0.09%	32,708 $5.01 Million
Q1 2022 May 09, 2022	SELL	$131.98 - $163.75 $52,791 - $65,500	-400 Reduced 1.21%	32,738 $5.31 Million
Q4 2021 Feb 08, 2022	BUY	$107.43 - $135.93 $21,486 - $27,186	200 Added 0.61%	33,138 $4.49 Million
Q3 2021 Nov 08, 2021	BUY	$106.4 - $120.78 $36,176 - $41,065	340 Added 1.04%	32,938 $3.55 Million
Q2 2021 Aug 03, 2021	BUY	$105.21 - $117.21 $126,251 - $140,652	1,200 Added 3.82%	32,598 $3.67 Million
Q1 2021 Apr 30, 2021	BUY	$102.3 - $112.62 $301,785 - $332,229	2,950 Added 10.37%	31,398 $3.4 Million
Q4 2020 Feb 08, 2021	BUY	$80.49 - $108.67 $83,307 - $112,473	1,035 Added 3.78%	28,448 $3.05 Million
Q3 2020 Nov 04, 2020	BUY	$85.91 - $100.83 $34,364 - $40,332	400 Added 1.48%	27,413 $2.4 Million
Q2 2020 Jul 29, 2020	BUY	$73.37 - $98.18 $6,896 - $9,228	94 Added 0.35%	27,013 $2.65 Million
Q1 2020 Apr 30, 2020	SELL	$64.5 - $97.79 $32,572 - $49,383	-505 Reduced 1.84%	26,919 $2.05 Million
Q4 2019 Jan 31, 2020	BUY	$72.13 - $90.25 $25,245 - $31,587	350 Added 1.29%	27,424 $2.43 Million
Q3 2019 Nov 01, 2019	BUY	$62.98 - $75.72 $43,456 - $52,246	690 Added 2.62%	27,074 $2.05 Million
Q2 2019 Aug 07, 2019	BUY	$65.7 - $83.98 $6,570 - $8,398	100 Added 0.38%	26,384 $1.92 Million
Q1 2019 Apr 24, 2019	BUY	$77.14 - $90.79 $121,495 - $142,994	1,575 Added 6.37%	26,284 $2.12 Million
Q4 2018 Feb 07, 2019	SELL	$77.85 - $96.01 $44,763 - $55,205	-575 Reduced 2.27%	24,709 $2.28 Million
Q3 2018 Nov 07, 2018	BUY	$88.91 - $98.84 $42,676 - $47,443	480 Added 1.94%	25,284 $2.39 Million
Q2 2018 Aug 03, 2018	BUY	$89.78 - $106.23 $73,170 - $86,577	815 Added 3.4%	24,804 $2.3 Million
Q1 2018 Apr 26, 2018	BUY	$92.01 - $123.21 $5,244 - $7,022	57 Added 0.24%	23,989 $2.27 Million
Q4 2017 Jan 26, 2018	BUY	$89.56 - $98.21 $1,791 - $1,964	20 Added 0.08%	23,932 $2.31 Million
Q2 2017 Aug 08, 2017	BUY	N/A	23,912	23,912 $1.73 Million

Others Institutions Holding ABBV

# of Institutions

3,699

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schulhoff & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Schulhoff & CO Inc with notifications on news.

Account